Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

María Inés Molejon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4470-6622; OpenAlex author ID A5058409659. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: 3 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 8

  1. Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in pancreatic cancer cells. Co-author DOI 10.1186/s12934-024-02395-0↗
  2. Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.25745↗
  3. The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation. First author DOI 10.1038/cddis.2016.202↗
  4. IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-15-0896↗
  5. Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence. Co-author DOI 10.18632/oncoscience.172↗
  6. Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.3510↗
  7. Chemotherapy and autophagy-mediated cell death in pancreatic cancer cells. Co-author DOI 10.1016/j.pan.2011.11.003↗
  8. Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. Co-author DOI 10.1172/jci60144↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Iovanna · 6 shared papers, 2012–2018 · strength 0.31
  2. Gisela Weiz · 1 shared paper, 2024 · strength 0.26
  3. Javier D. Breccia · 1 shared paper, 2024 · strength 0.26
  4. Martín E. Fernández-Zapico · 1 shared paper, 2024 · strength 0.26
  5. Nelson Dusetti · 3 shared papers, 2015–2016 · strength 0.15
  6. Céline Loncle · 3 shared papers, 2015–2016 · strength 0.14
  7. Odile Gayet · 2 shared papers, 2015–2018 · strength 0.13
  8. Raul A. Urrutia · 3 shared papers, 2012–2016 · strength 0.13
  9. Gwen Alyce Lomberk · 3 shared papers, 2012–2016 · strength 0.13
  10. Mehdi Ouaïssi · 2 shared papers, 2015 · strength 0.09
  11. Olivıer Turrini · 2 shared papers, 2015 · strength 0.09
  12. Mirna Swayden · 1 shared paper, 2018 · strength 0.09
  13. Daniele Fanale · 1 shared paper, 2018 · strength 0.09
  14. Jennifer Bintz · 1 shared paper, 2018 · strength 0.09
  15. Philippe Soubeyran · 1 shared paper, 2018 · strength 0.09
  16. Jean‐Robert Delpéro · 1 shared paper, 2015 · strength 0.05
  17. Emma Folch‐Puy · 1 shared paper, 2015 · strength 0.04
  18. Eduardo Chuluyán · 1 shared paper, 2015 · strength 0.04
  19. Daniel Closa · 1 shared paper, 2015 · strength 0.04
  20. Pierre Cordelier · 1 shared paper, 2015 · strength 0.04
  21. Flora Poizat · 1 shared paper, 2015 · strength 0.04
  22. Pauline Duconseil · 1 shared paper, 2015 · strength 0.04
  23. Marine Gilabert · 1 shared paper, 2015 · strength 0.04
  24. Alejandro Ropolo · 1 shared paper, 2012 · strength 0.03
  25. María I. Vaccaro · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.